- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02628158
Fundus Autofluorescence After Vitrectomy for Epiretinal Membrane
December 8, 2015 updated by: Makoto Inoue, Kyorin University
Correlation of Postoperative Vision and Fundus Autofluorescence After Vitrectomy for Epiretinal Membrane
Fundus autofluorescence (FAF) at the macula originates from hyperfluorescence from retinal pigment epithelium (RPE) and blockage of hyperfluorescence by macular pigment.
Investigators evaluate whether presence of FAF may correlate to the postoperative visual outcome for epiretinal membrane.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
92 eyes with epiretinal membrane were performed vitreous surgery, epiretinal membrane removal and internal limiting membrane (ILM) peeling.
Presence of hyperfluorescence in FAF at the macular area and best-corrected visual acuity (BCVA) was evaluated preoperatively and at postoperative 1, 3, and 6 months with ultra-wide angle imaging.
Study Type
Observational
Enrollment (Actual)
91
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Tokyo
-
Mitaka, Tokyo, Japan, 181-8611
- Kyorin Eye Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
The patients with epiretinal membrane who underwent vitrectomy with epiretinal membrane and internal limiting membrane removal
Description
Inclusion Criteria:
- The inclusion criteria were patients who underwent vitrectomy and internal limiting membrane removal for epiretinal membrane and had followed for more than 6 months.
Exclusion Criteria:
- The patients with follow-up less than 6 months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual acuity before and after surgery
Time Frame: Changes from baseline to 1, 3, 6 months
|
Vision
|
Changes from baseline to 1, 3, 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Presence of fluids autofluorescence at the macular area
Time Frame: Changes from baseline up to 6 months
|
Fundus autofluorescence
|
Changes from baseline up to 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2013
Primary Completion (Actual)
April 1, 2015
Study Completion (Actual)
October 1, 2015
Study Registration Dates
First Submitted
December 6, 2015
First Submitted That Met QC Criteria
December 8, 2015
First Posted (Estimate)
December 11, 2015
Study Record Updates
Last Update Posted (Estimate)
December 11, 2015
Last Update Submitted That Met QC Criteria
December 8, 2015
Last Verified
December 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Kyorineye019
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epiretinal Membrane
-
Medical University of GrazCompletedEpiretinal Membrane of Both EyesAustria
-
Centre Hospitalier Universitaire DijonTerminatedEpiretinal Membrane SurgeryFrance
-
University of RegensburgCompletedIdiopathic Epiretinal Membrane, CataractGermany
-
Centre Hospitalier Universitaire DijonCompletedEpiretinal Membranes
-
Centre Hospitalier Universitaire DijonRecruitingSurgery for Cataract | Surgery for and Idiopathic Epiretinal MembraneFrance
-
Vienna Institute for Research in Ocular SurgeryCompleted
-
The Ludwig Boltzmann Institute of Retinology and...Completed
-
Nantes University HospitalCompleted
-
IRCCS Policlinico S. MatteoCompleted
-
Changhua Christian HospitalCompletedEpiretinal Membrane | Internal Limiting Membrane WrinklingTaiwan
Clinical Trials on Vitrectomy with internal limiting membrane removal
-
Kyorin UniversityCompletedMyopic Traction MaculopathyJapan
-
Tanta UniversityCompletedMyopic Traction Maculopathy | Pars Plana Vitrectomy | Internal Limiting Membrane Peeling
-
IRCCS Policlinico S. MatteoCompleted
-
Minia UniversityCompletedMaculopathy | Optic Disc Structural Anomaly
-
Samsung Medical CenterUnknownEpiretinal MembraneKorea, Republic of
-
Hospital Oftalmologico de SorocabaActive, not recruiting
-
Instituto de Oftalmología Fundación Conde de ValencianaRecruiting
-
Seoul National University HospitalActive, not recruitingEpiretinal Membrane | Retinal DiseaseKorea, Republic of
-
Assistance Publique - Hôpitaux de ParisCompleted